Centrical Secures $39 Million in Latest Pre-Seed Funding Round

Centrical secured $39 million in its latest Pre-Seed, adding another data point to the Healthcare & Life Sciences funding market.

Centrical Raises $39 million in Funding

Centrical is a Digital Health company focused on expand AI frontline performance platform.

Investors Behind the Funding

The round was backed by Psychedelic Therapies. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Centrical operates in Healthcare & Life Sciences. Centrical's Pre-Seed round shows investors are still backing digital health platforms with real scale narratives. At $39M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

expand AI frontline performance platform

Looking Ahead

Centrical raises $39M to expand AI frontline performance platform

Source reference: original announcement/article.